Sat.Aug 22, 2020 - Fri.Aug 28, 2020

article thumbnail

Sharing oncology trial PROs to build the treatment of the future

pharmaphorum

Could collecting, understanding, and disseminating patient-reported outcomes during trials be the key to advancing oncology treatments and improving cancer outcomes? . With our understanding of cancer accelerating at an unprecedented rate, and personalised medicines on the cusp of becoming mainstream, regulatory bodies need new ways to assess products. .

Labelling 128
article thumbnail

Breaking FDA COVID-19 news

Outsourcing Pharma

The agency continues to take actions and issue advice related to COVID-19 treatments, tests, consumer products and other pressing industry concerns.

FDA 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Top 10 sore throat lozenges | Sore throat treatment

Druggist

Sore throat is a common condition usually caused by a viral infection, and less commonly by a bacterial infection. A sore throat usually lasts about one week. It is a self-limiting condition meaning it goes on its own without treatment. There is no treatment for a sore throat caused by a viral infection. Even when a sore throat is caused by a bacterial infection, in most cases, patients will get better without antibiotic treatment (NICE, 2018).

article thumbnail

Adapting Customer Engagement Strategies to the COVID Landscape

Pharma Marketing Network

The pharmaceutical industry has been under pressure for the past decade to change its go-to-market models. While the industry has attempted change, any change to its approach has been guarded. But the industry’s new challenge—marketing and selling in a COVID-19 environment—abruptly changes the customer interaction landscape, perhaps permanently. In office/in person sales promotion, the staple of pharmaceutical company activities, is simply not possible today with interactions reduced to the spor

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Pain-detecting tool for dementia patients rolls out in UK

pharmaphorum

Normal. 0. false. false. false. EN-GB. X-NONE. X-NONE. A smartphone-based app that uses facial analysis technology to spot chronic pain in people with dementia, called PainChek, is being rolled out in the UK by its Australian developer. The artificial intelligence-powered tool can help care workers and clinicians to identify and manage pain in patients with conditions like Alzheimer’s disease that can make it difficult for them to communicate.

article thumbnail

SubjectWell eyes diversity in COVID-19 vaccine trials

Outsourcing Pharma

The clinical trials marketplace company reportedly is connecting sites with 10,000 patients a month, with 40% of them from non-white groups.

More Trending

article thumbnail

GSK bags EU approval for Blenrep

Pharma Times

Blenrep is a first-line inhibitor of BCMA, a cell-surface protein that plays a crucial role in the survival of plasma cells and is expressed on multiple myeloma cells

55
article thumbnail

COVID-19 is causing a renaissance in the UK biotech sector, we must ensure it lasts

pharmaphorum

Despite the UK’s world class research output and the many start-ups successfully spinning out from its academic institutions, in recent years UK biotech companies have struggled to access the capital they need to scale up and make their mark on the industry. The COVID-19 pandemic has brought about a radical transformation, with investors now eager to fund companies involved in the fight against the virus.

Vaccines 122
article thumbnail

Study looks at COVID-era mobile health applications

Outsourcing Pharma

Led by the Spaulding Rehabilitation Hospital, a study by a 60-person task force shows ways mobile health tech can help mitigate the pandemicâs effects.

article thumbnail

What Is the Difference Between Oxygen Generators and CPAP?

Pharma Mirror

A CPAP machine is a device that can replace or improve human breathing, increase lung ventilation, and improve respiratory function. It is generally used for lung failure or airway obstruction to breathing normally to help the patient complete the breathing process of inhalation and exhalation. It has a variety of breathing modes (various ways in. The post What Is the Difference Between Oxygen Generators and CPAP?

52
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

AbbVie submits Rinvoq for ankylosing spondylitis

Pharma Times

In a pivotal Phase II/III study, twice as many patients receiving the drug achieved the primary endpoint of ASAS 40 response at week 14 versus placebo

52
article thumbnail

Humana lawsuit exposes fraud risk in high-growth telehealth market

pharmaphorum

Health insurer Humana has filed a lawsuit against telemedicine company QuivvyTech that it says resulted in fraudulent prescriptions worth millions of dollars being written for duped customers. According to the complaint, QuivvyTech hired telemarketers to cold-call Humana members, whose details were obtained using “illegal means,” and encouraged them to talk about common ailments, claiming to be calling from Humana.

Insurance 122
article thumbnail

Eversana partners on migraine treatment launch

Outsourcing Pharma

The company is joining with Zosano Pharma to aid the commercialization and distribution of Qtrypta, a transdermal migraine treatment candidate.

78
article thumbnail

A review Commentary on Quinidine kinetics (PK modelling)

Pharma Tutor

About Author. Mohd Riyaz Beg1* 1. Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Mumbai. *Corresponding author’s. email: phm19mr.beg@pg.ictmumbai.edu.in; mohdriyazbeg@gmail.

52
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Drive In Movie Night Magic

Dr. Jamie Hardy: The Lifestyle Pharmacist

Omgeeeee #FABSQUAD ! Life BC (before COVID) was pretty different for me and my family. Our downtime was spent traveling to our favorite cities around the US at least monthly and enjoying an. international vacation every summer. On normal weekends we would gather together for food and fellowship at local restaurants or at my parent’s house. Fast forward 5 months.

52
article thumbnail

Moderna’s COVID vaccine works in older people, according to new data

pharmaphorum

Moderna has said that its coronavirus vaccine stimulated an immune response in older people in phase 1 trials, suggesting that the jab is effective in the age groups most susceptible to COVID-19. An analysis of the latest data from a phase 1 trial showed that in 20 older adults given the vaccine – ten between the ages of 56 and 70 and ten aged 71 and older – the vaccine produced neutralising antibodies and T-cells in comparable levels to those aged 18 to 55-years-old.

Vaccines 111
article thumbnail

Thread Research lands $50m infusion for decentralized trial tech

Outsourcing Pharma

The clinical research tech provider has received a capital commitment from healthcare industry investors to advance its decentralized trial solutions.

72
article thumbnail

Kidney cancer charity slams NICE rejection of Keytruda/Inlyta

Pharma Times

NICE says the combination's cost-effectiveness estimate is higher than what is considered acceptable for NHS use

47
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Free Pharmacology Course – No Strings Attached

Med Ed 101

I can’t thank you all enough for the support and as always I like to provide some free resources (in addition to the blog and podcast) along the way! I’ve just recently released a free pharmacology course on Udemy.com. The general overview of the course is on pharmacodynamics and pharmacokinetics. I focused primarily on common […].

40
article thumbnail

Industry group says FDA botched COVID-19 convalescent plasma guidance

pharmaphorum

Already under fire for what some view as a premature authorisation of convalescent plasma for COVID-19, the FDA is now being accused of a blunder that could render current supplies unusable. Bioindustry association MichBio says the FDA’s labelling requirements for COVID-19 convalescent plasma (CCP) – which were published alongside the emergency use authorisation – could lead to “hundreds, if not thousands, of in-date, ready to transfuse CCP units across the country being rendered unusable.”.

FDA 105
article thumbnail

Colorcon invests in AI-centric drug discovery

Outsourcing Pharma

The pharmaceutical technology investment fund is partnering with and financing Atomwise, a company that provides AI solutions for drug discovery.

65
article thumbnail

Scancell receives funding for COVID-19 vaccine development

Pharma Times

It is hoped that the vaccine will generate protection not only against SARS-CoV-2, but also against new strains of coronavirus that may arise in the future

article thumbnail

The first mobile processing machine for pilot scale applications – VENTILUS® Pilot by Romaco Innojet

Pharma Mirror

Romaco Innojet has just developed the first mobile processing machine for pilot scale applications. The VENTILUS® Pilot represents an all-in-one solution both for laboratories and for manufacturers of small batch sizes. The system design with only one spray nozzle simplifies scale-up processes. Romaco Innojet has just launched the first mobile processing machine in the market.

40
article thumbnail

Bayer strikes $98m deal with digital health firm One Drop

pharmaphorum

Bayer has taken a further stake in New York-based One Drop to support its plans to become a digital health business by developing new integrated care services for patients. The German pharmaceutical company will work with One Drop on digital health products that span multiple therapeutic areas, with Bayer citing oncology, cardiovascular diseases and women’s health as potential targets.

article thumbnail

TFF, Union Therapeutics join on potential COVID-19 treatment

Outsourcing Pharma

The companies will partner on developing dry-powder forms of niclosamide as a treatment for the virus, using thin-film freezing technology.

59
article thumbnail

Ophthalmic Timolol and Hypotension – More Than What Meets The Eye

Med Ed 101

Timolol is an effective medication for reducing intraocular pressure in patients with glaucoma. The recommended starting dose is one drop of timolol 0.25% ophthalmic solution in the affected eye(s) twice daily. It is a non-selective beta-blocker. Ophthalmic administration does not prevent systemic absorption and effects. In patients with significant hypotension, falls, or bradycardia of unknown […].

40
article thumbnail

Clinical research cut 87% at peak of pandemic

Pharma Times

The model suggests that just 13% of full-time academics would have been available to carry out research during the height of the pandemic

39
article thumbnail

Amazon enters health wearables market with Halo service

pharmaphorum

Amazon has launched a fitness band, app and subscription service – called Halo – that promises to look after both your body and mind. The e-commerce giant’s entry into the health wearables market combines monitoring of physical data such as activity levels, sleep patterns and body fat with artificial intelligence (AI) algorithms that listen for the emotion in a user’s voice.

article thumbnail

ERT, Science 37 forge virtual trial data partnership

Outsourcing Pharma

The companies will work together on solutions designed to enable sponsors to improve imaging, respiratory and cardiac safety data on decentralized trials.

52
article thumbnail

Behind the scenes of the new ABPI Code of Practice

pharmaphorum

For over 60 years the ABPI Code of Practice has been key to the UK industry’s self-regulation, and now, as pharma is experiencing its most intense period of change in decades, a new update seeks to bring the Code in line with the modern sector. With the new Code now in its consultation stage, we spoke to ABPI president Haseeb Ahmad to find out more about the key changes.

article thumbnail

COVID-19’s lasting impact on digital communication in healthcare

pharmaphorum

The ongoing digital transformation of the healthcare and pharmaceutical industries has been greatly accelerated during the coronavirus pandemic. In The Medscape Professional Networks’ latest white paper, Healthcare’s New Normal: COVID Speeds Shift to Digital Communications , key opinion leaders and industry experts agree that in the post-pandemic world, even as lockdowns are lifted and restrictions relaxed, the emerging trends for an increase in digital communications will stay.

article thumbnail

Chasing Regeneron, AZ starts trials of its COVID-19 antibody cocktail

pharmaphorum

The first patients have been dosed in a trial of two AstraZeneca antibodies, collectively known as AZD7442, that are being developed to both treat and prevent coronavirus infections. The phase 1 trial – funded by the US government – will take place in the UK and will test the safety of AZD7442 and its pharmacokinetic profile. It will enrol up to 48 people aged 18 to 55, and is expected to generate results before the end of the year. .

FDA 84
article thumbnail

Takeda agrees $2.3bn sale of Japanese consumer health unit

pharmaphorum

Takeda has joined the ranks of big pharma companies jettisoning consumer health businesses in order to concentrate on higher-margin prescription drugs. The drugmaker is divesting Takeda Consumer Healthcare, which operates mainly in Japan, to private equity group Blackstone for 242 billion yen ($2.3 billion), with the deal expected to close in March of next year.

80